Covered recipient · General Payments record
SOHAIB MAJEED
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$28,416.54
- Reported across 299 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,914.16 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $1,378.89 | 12 |
| Abbott Laboratories | $783.43 | 5 |
| Amgen Inc. | $246.80 | 2 |
| Mallinckrodt Hospital Products Inc. | $149.99 | 1 |
| SANOFI-AVENTIS U.S. LLC | $118.71 | 1 |
| Xeris Pharmaceuticals, Inc. | $118.71 | 1 |
| Merck Sharp & Dohme Corporation | $63.00 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $54.63 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $177.11 | 03/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125042740 | CMS |
| Abbott Laboratories | $116.38 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125042742 | CMS |
| Abbott Laboratories | $161.51 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125042744 | CMS |
| Abbott Laboratories | $178.44 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125042748 | CMS |
| Abbott Laboratories | $149.99 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125042746 | CMS |
| ABBVIE INC. | $118.50 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104933883 | CMS |
| ABBVIE INC. | $125.00 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104933887 | CMS |
| ABBVIE INC. | $124.99 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104933891 | CMS |
| ABBVIE INC. | $125.00 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104933894 | CMS |
| ABBVIE INC. | $104.74 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104933899 | CMS |
| ABBVIE INC. | $124.99 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104933903 | CMS |
| ABBVIE INC. | $92.34 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104933907 | CMS |
| ABBVIE INC. | $118.07 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104933911 | CMS |
| ABBVIE INC. | $109.35 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104933915 | CMS |
| ABBVIE INC. | $90.03 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104933918 | CMS |
| ABBVIE INC. | $122.20 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104933923 | CMS |
| ABBVIE INC. | $123.68 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104933927 | CMS |
| Amgen Inc. | $125.36 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117617754 | CMS |
| Amgen Inc. | $121.44 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117617756 | CMS |
| Mallinckrodt Hospital Products Inc. | $149.99 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145102574 | CMS |
| Merck Sharp & Dohme LLC | $15.75 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141742287 | CMS |
| Merck Sharp & Dohme LLC | $15.75 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141884295 | CMS |
| Merck Sharp & Dohme LLC | $15.75 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141742289 | CMS |
| Merck Sharp & Dohme LLC | $15.75 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141884297 | CMS |
| Novartis Pharmaceuticals Corporation | $29.63 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087148566 | CMS |
| Novartis Pharmaceuticals Corporation | $25.00 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087148574 | CMS |
| SANOFI-AVENTIS U.S. LLC | $118.71 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139836798 | CMS |
| Xeris Pharmaceuticals, Inc. | $118.71 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144613906 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.